KPV is a synthetic tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH), widely studied in laboratory settings for its interaction with inflammatory signalling pathways and cellular immune responses. Its well-characterised biological activity has made it a key compound in research involving immunology, epithelial biology and inflammatory regulation.

In controlled research environments, KPV is commonly used in studies exploring cytokine signalling, immune cell activity, epithelial barrier function, inflammatory response mechanisms and peptide pharmacology. Its well-characterised synthetic structure and high purity make it suitable for advanced in-vitro applications requiring consistency, analytical reliability and reproducible research outcomes.